The results of several studies have demonstrated the importance of phosphorylated eIF2α (p-eIF2α) in cancer therapy [10], [13], [14]: activation of the PKR-eIF2a phosphorylation pathway is essential for the antiproliferative and proapoptotic functions of the tumor suppressor gene [15]. This evidence concerns the gene EIF2A and cancer.